Digital Specialty Chemicals Limited (DSC), a dual bottom line corporation and leading provider of advanced materials to the semiconductor, pharmaceutical, and specialty chemical markets, announced today that it has received an equity investment from Intel Capital, Intel Corporation’s global investment organization. The investment will enhance the company’s research and development capabilities and will accelerate manufacturing capacity expansion.
“Since 1987, we have provided custom and high volume high purity chemicals to the semiconductor, pharmaceutical and specialty chemical markets worldwide. Our people, processes and facilities combine to offer the agility of a small, fine- chemical operation with the capacity of a large supplier,” said Dr. Ravi R. Gukathasan, CEO. “We believe that the continuation of Moore’s Law for semiconductor processing will depend greatly on continued innovation of advanced precursors which provides a growth opportunity for DSC. The funding from Intel Capital will help enable us to construct state-of-the-art R&D and manufacturing facilities to meet growing demand for thin film technologies.”
“Materials innovation is critical to enabling new capabilities in semiconductor device design and manufacturing,” said Robert Bruck, corporate vice president and general manager of Global Supply Management at Intel. “We look forward to supporting DSC’s growth including development of new materials technologies for advanced semiconductor manufacturing process technology nodes.”
No comments:
Post a Comment